Financial Metrics

ELV Elevance Health, Inc.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	2.63	—	USD/shares	10-Q	2017-04-26
Quarterly	2016-06-30	2.91	+10.6%	USD/shares	10-Q	2017-07-26
Quarterly	2016-09-30	2.3	-21.0%	USD/shares	10-Q	2017-10-25
Quarterly	2017-03-31	3.73	+62.2%	USD/shares	10-Q	2018-04-25
Quarterly	2017-06-30	3.16	-15.3%	USD/shares	10-Q	2018-07-25
Quarterly	2017-09-30	2.8	-11.4%	USD/shares	10-Q	2018-10-31
Quarterly	2018-03-31	4.99	+78.2%	USD/shares	10-Q	2019-04-24
Quarterly	2018-06-30	3.98	-20.2%	USD/shares	10-Q	2019-07-24
Quarterly	2018-09-30	3.62	-9.0%	USD/shares	10-Q	2019-10-23
Quarterly	2019-03-31	5.91	+63.3%	USD/shares	10-Q	2020-04-29
Quarterly	2019-06-30	4.36	-26.2%	USD/shares	10-Q	2020-07-29
Quarterly	2019-09-30	4.55	+4.4%	USD/shares	10-Q	2020-10-28
Quarterly	2020-03-31	5.94	+30.5%	USD/shares	10-Q	2021-04-21
Quarterly	2020-06-30	8.91	+50.0%	USD/shares	10-Q	2021-07-21
Quarterly	2020-09-30	0.87	-90.2%	USD/shares	10-Q	2021-10-20
Quarterly	2020-12-31	17.98	+1966.7%	USD/shares	10-Q	2023-10-18
Quarterly	2021-03-31	6.71	-62.7%	USD/shares	10-Q	2022-04-20
Quarterly	2021-06-30	7.25	+8.0%	USD/shares	10-Q	2022-07-20
Quarterly	2021-09-30	6.13	-15.4%	USD/shares	10-Q	2022-10-19
Quarterly	2021-12-31	24.95	+307.0%	USD/shares	10-Q	2023-10-18
Quarterly	2022-03-31	7.32	-70.7%	USD/shares	10-Q	2023-04-19
Quarterly	2022-06-30	6.73	-8.1%	USD/shares	10-Q/A	2023-09-29
Quarterly	2022-09-30	6.62	-1.6%	USD/shares	10-Q	2023-10-18
Quarterly	2022-12-31	24.28	+266.8%	USD/shares	10-Q	2023-10-18
Quarterly	2023-03-31	8.3	-65.8%	USD/shares	10-Q	2024-04-18
Quarterly	2023-06-30	7.79	-6.1%	USD/shares	10-Q	2024-07-17
Quarterly	2023-09-30	5.45	-30.0%	USD/shares	10-Q	2024-10-17
Quarterly	2024-03-31	9.59	+76.0%	USD/shares	10-Q	2025-04-22
Quarterly	2024-06-30	9.85	+2.7%	USD/shares	10-Q	2025-07-17
Quarterly	2024-09-30	4.36	-55.7%	USD/shares	10-Q	2025-10-21
Quarterly	2025-03-31	9.61	+120.4%	USD/shares	10-Q	2025-04-22
Quarterly	2025-06-30	7.72	-19.7%	USD/shares	10-Q	2025-07-17
Quarterly	2025-09-30	5.32	-31.1%	USD/shares	10-Q	2025-10-21
Annual	2016-12-31	9.21	—	USD/shares	10-K	2019-02-20
Annual	2017-12-31	14.35	+55.8%	USD/shares	10-K	2020-02-19
Annual	2018-12-31	14.19	-1.1%	USD/shares	10-K	2021-02-18
Annual	2019-12-31	18.47	+30.2%	USD/shares	10-K	2022-02-16
Annual	2020-12-31	17.98	-2.7%	USD/shares	10-K	2023-02-15
Annual	2021-12-31	24.95	+38.8%	USD/shares	10-K	2024-02-21
Annual	2022-12-31	24.28	-2.7%	USD/shares	10-K	2025-02-20
Annual	2023-12-31	25.22	+3.9%	USD/shares	10-K	2026-02-06
Annual	2024-12-31	25.68	+1.8%	USD/shares	10-K	2026-02-06
Annual	2025-12-31	25.21	-1.8%	USD/shares	10-K	2026-02-06

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	14864500000.0	—	USD	10-Q	2016-04-27
Quarterly	2016-06-30	14202400000.0	-4.5%	USD	10-Q	2016-07-27
Quarterly	2016-09-30	14242300000.0	+0.3%	USD	10-Q	2016-11-02
Quarterly	2016-12-31	14358500000.0	+0.8%	USD	10-Q	2017-10-25
Quarterly	2017-03-31	15449900000.0	+7.6%	USD	10-Q	2017-04-26
Quarterly	2017-06-30	15088000000.0	-2.3%	USD	10-Q	2017-07-26
Quarterly	2017-09-30	13777300000.0	-8.7%	USD	10-Q	2017-10-25
Quarterly	2017-12-31	17382000000.0	+26.2%	USD	10-Q	2018-10-31
Quarterly	2018-03-31	18110100000.0	+4.2%	USD	10-Q	2018-04-25
Quarterly	2018-06-30	17515400000.0	-3.3%	USD	10-Q	2018-07-25
Quarterly	2018-09-30	17300000000.0	-1.2%	USD	10-Q	2018-10-31
Quarterly	2018-12-31	17217000000.0	-0.5%	USD	10-Q	2019-10-23
Quarterly	2019-03-31	17396000000.0	+1.0%	USD	10-Q	2019-04-24
Quarterly	2019-06-30	17436000000.0	+0.2%	USD	10-Q	2019-07-24
Quarterly	2019-09-30	18820000000.0	+7.9%	USD	10-Q	2019-10-23
Quarterly	2019-12-31	17787000000.0	-5.5%	USD	10-Q	2020-10-28
Quarterly	2020-03-31	300000000.0	-98.3%	USD	10-Q	2020-04-29
Quarterly	2020-06-30	19873000000.0	+6524.3%	USD	10-Q	2020-07-29
Quarterly	2020-09-30	19094000000.0	-3.9%	USD	10-Q	2020-10-28
Quarterly	2020-12-31	19335000000.0	+1.3%	USD	10-Q	2021-10-20
Quarterly	2021-03-31	22534000000.0	+16.5%	USD	10-Q	2021-04-21
Quarterly	2021-06-30	22217000000.0	-1.4%	USD	10-Q	2021-07-21
Quarterly	2021-09-30	21761000000.0	-2.1%	USD	10-Q	2021-10-20
Quarterly	2021-12-31	22756000000.0	+4.6%	USD	10-Q	2023-10-18
Quarterly	2022-03-31	19883000000.0	-12.6%	USD	10-Q	2022-04-20
Quarterly	2022-06-30	21165000000.0	+6.4%	USD	10-Q	2022-07-20
Quarterly	2022-09-30	21258000000.0	+0.4%	USD	10-Q	2022-10-19
Quarterly	2022-12-31	23849000000.0	+12.2%	USD	10-Q	2023-10-18
Quarterly	2023-03-31	25201000000.0	+5.7%	USD	10-Q	2023-04-19
Quarterly	2023-06-30	24859000000.0	-1.4%	USD	10-Q/A	2023-09-29
Quarterly	2023-09-30	24045000000.0	-3.3%	USD	10-Q	2023-10-18
Quarterly	2023-12-31	23246000000.0	-3.3%	USD	10-Q	2024-10-17
Quarterly	2024-03-31	21976000000.0	-5.5%	USD	10-Q	2024-04-18
Quarterly	2024-06-30	24561000000.0	+11.8%	USD	10-Q	2024-07-17
Quarterly	2024-09-30	24688000000.0	+0.5%	USD	10-Q	2024-10-17
Quarterly	2024-12-31	29218000000.0	+18.3%	USD	10-Q	2025-10-21
Quarterly	2025-03-31	28110000000.0	-3.8%	USD	10-Q	2025-04-22
Quarterly	2025-06-30	28178000000.0	+0.2%	USD	10-Q	2025-07-17
Quarterly	2025-09-30	31173000000.0	+10.6%	USD	10-Q	2025-10-21
Annual	2016-12-31	15286900000.0	—	USD	10-K	2018-02-21
Annual	2017-12-31	18657000000.0	+22.0%	USD	10-K	2019-02-20
Annual	2018-12-31	18066000000.0	-3.2%	USD	10-K	2020-02-19
Annual	2019-12-31	19385000000.0	+7.3%	USD	10-K	2021-02-18
Annual	2020-12-31	20035000000.0	+3.4%	USD	10-K	2022-02-16
Annual	2021-12-31	22756000000.0	+13.6%	USD	10-K	2023-02-15
Annual	2022-12-31	23849000000.0	+4.8%	USD	10-K	2024-02-21
Annual	2023-12-31	24895000000.0	+4.4%	USD	10-K	2025-02-20
Annual	2024-12-31	30867000000.0	+24.0%	USD	10-K	2026-02-06
Annual	2025-12-31	31896000000.0	+3.3%	USD	10-K	2026-02-06

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	117500000.0	—	USD	10-Q	2017-04-26
Quarterly	2016-06-30	251200000.0	+113.8%	USD	10-Q	2017-07-26
Quarterly	2016-09-30	415600000.0	+65.4%	USD	10-Q	2017-10-25
Quarterly	2017-03-31	127900000.0	-69.2%	USD	10-Q	2018-04-25
Quarterly	2017-06-30	297500000.0	+132.6%	USD	10-Q	2018-07-25
Quarterly	2017-09-30	516000000.0	+73.4%	USD	10-Q	2018-10-31
Quarterly	2018-03-31	218000000.0	-57.8%	USD	10-Q	2019-04-24
Quarterly	2018-06-30	533000000.0	+144.5%	USD	10-Q	2019-07-24
Quarterly	2018-09-30	888000000.0	+66.6%	USD	10-Q	2019-10-23
Quarterly	2019-03-31	234000000.0	-73.6%	USD	10-Q	2020-04-29
Quarterly	2019-06-30	455000000.0	+94.4%	USD	10-Q	2020-07-29
Quarterly	2019-09-30	726000000.0	+59.6%	USD	10-Q	2020-10-28
Quarterly	2020-03-31	204000000.0	-71.9%	USD	10-Q	2021-04-21
Quarterly	2020-06-30	437000000.0	+114.2%	USD	10-Q	2021-07-21
Quarterly	2020-09-30	743000000.0	+70.0%	USD	10-Q	2021-10-20
Quarterly	2020-12-31	1021000000.0	+37.4%	USD	10-Q	2023-10-18
Quarterly	2021-03-31	204000000.0	-80.0%	USD	10-Q	2022-04-20
Quarterly	2021-06-30	489000000.0	+139.7%	USD	10-Q	2022-07-20
Quarterly	2021-09-30	747000000.0	+52.8%	USD	10-Q	2022-10-19
Quarterly	2021-12-31	1087000000.0	+45.5%	USD	10-Q	2023-10-18
Quarterly	2022-03-31	254000000.0	-76.6%	USD	10-Q	2023-04-19
Quarterly	2022-06-30	549000000.0	+116.1%	USD	10-Q/A	2023-09-29
Quarterly	2022-09-30	854000000.0	+55.6%	USD	10-Q	2023-10-18
Quarterly	2022-12-31	1152000000.0	+34.9%	USD	10-Q	2023-10-18
Quarterly	2023-03-31	301000000.0	-73.9%	USD	10-Q	2024-04-18
Quarterly	2023-06-30	651000000.0	+116.3%	USD	10-Q	2024-07-17
Quarterly	2023-09-30	970000000.0	+49.0%	USD	10-Q	2024-10-17
Quarterly	2024-03-31	279000000.0	-71.2%	USD	10-Q	2025-04-22
Quarterly	2024-06-30	602000000.0	+115.8%	USD	10-Q	2025-07-17
Quarterly	2024-09-30	934000000.0	+55.1%	USD	10-Q	2025-10-21
Quarterly	2025-03-31	196000000.0	-79.0%	USD	10-Q	2025-04-22
Quarterly	2025-06-30	463000000.0	+136.2%	USD	10-Q	2025-07-17
Quarterly	2025-09-30	823000000.0	+77.8%	USD	10-Q	2025-10-21
Annual	2016-12-31	584000000.0	—	USD	10-K	2019-02-20
Annual	2017-12-31	791000000.0	+35.4%	USD	10-K	2020-02-19
Annual	2018-12-31	1208000000.0	+52.7%	USD	10-K	2021-02-18
Annual	2019-12-31	1077000000.0	-10.8%	USD	10-K	2022-02-16
Annual	2020-12-31	1021000000.0	-5.2%	USD	10-K	2023-02-15
Annual	2021-12-31	1087000000.0	+6.5%	USD	10-K	2024-02-21
Annual	2022-12-31	1152000000.0	+6.0%	USD	10-K	2025-02-20
Annual	2023-12-31	1296000000.0	+12.5%	USD	10-K	2026-02-06
Annual	2024-12-31	1256000000.0	-3.1%	USD	10-K	2026-02-06
Annual	2025-12-31	1116000000.0	-11.1%	USD	10-K	2026-02-06

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	267500000.0	—	shares	10-Q	2017-04-26
Quarterly	2016-06-30	268200000.0	+0.3%	shares	10-Q	2017-07-26
Quarterly	2016-09-30	268100000.0	-0.0%	shares	10-Q	2017-10-25
Quarterly	2017-03-31	270400000.0	+0.9%	shares	10-Q	2018-04-25
Quarterly	2017-06-30	270800000.0	+0.1%	shares	10-Q	2018-07-25
Quarterly	2017-09-30	267000000.0	-1.4%	shares	10-Q	2018-10-31
Quarterly	2018-03-31	262800000.0	-1.6%	shares	10-Q	2019-04-24
Quarterly	2018-06-30	264500000.0	+0.6%	shares	10-Q	2019-07-24
Quarterly	2018-09-30	265400000.0	+0.3%	shares	10-Q	2019-10-23
Quarterly	2019-03-31	262300000.0	-1.2%	shares	10-Q	2020-04-29
Quarterly	2019-06-30	261000000.0	-0.5%	shares	10-Q	2020-07-29
Quarterly	2019-09-30	260000000.0	-0.4%	shares	10-Q	2020-10-28
Quarterly	2020-03-31	256400000.0	-1.4%	shares	10-Q	2021-04-21
Quarterly	2020-06-30	255400000.0	-0.4%	shares	10-Q	2021-07-21
Quarterly	2020-09-30	254200000.0	-0.5%	shares	10-Q	2021-10-20
Quarterly	2020-12-31	254300000.0	+0.0%	shares	10-Q	2023-10-18
Quarterly	2021-03-31	248200000.0	-2.4%	shares	10-Q	2022-04-20
Quarterly	2021-06-30	247400000.0	-0.3%	shares	10-Q	2022-07-20
Quarterly	2021-09-30	246000000.0	-0.6%	shares	10-Q	2022-10-19
Quarterly	2021-12-31	246800000.0	+0.3%	shares	10-Q	2023-10-18
Quarterly	2022-03-31	244400000.0	-1.0%	shares	10-Q	2023-04-19
Quarterly	2022-06-30	243400000.0	-0.4%	shares	10-Q/A	2023-09-29
Quarterly	2022-09-30	242200000.0	-0.5%	shares	10-Q	2023-10-18
Quarterly	2022-12-31	242800000.0	+0.2%	shares	10-Q	2023-10-18
Quarterly	2023-03-31	239700000.0	-1.3%	shares	10-Q	2024-04-18
Quarterly	2023-06-30	237800000.0	-0.8%	shares	10-Q	2024-07-17
Quarterly	2023-09-30	236500000.0	-0.5%	shares	10-Q	2024-10-17
Quarterly	2024-03-31	234200000.0	-1.0%	shares	10-Q	2025-04-22
Quarterly	2024-06-30	233400000.0	-0.3%	shares	10-Q	2025-07-17
Quarterly	2024-09-30	233100000.0	-0.1%	shares	10-Q	2025-10-21
Quarterly	2025-03-31	227200000.0	-2.5%	shares	10-Q	2025-04-22
Quarterly	2025-06-30	225800000.0	-0.6%	shares	10-Q	2025-07-17
Quarterly	2025-09-30	223700000.0	-0.9%	shares	10-Q	2025-10-21
Annual	2016-12-31	268100000.0	—	shares	10-K	2019-02-20
Annual	2017-12-31	267800000.0	-0.1%	shares	10-K	2020-02-19
Annual	2018-12-31	264200000.0	-1.3%	shares	10-K	2021-02-18
Annual	2019-12-31	260300000.0	-1.5%	shares	10-K	2022-02-16
Annual	2020-12-31	254300000.0	-2.3%	shares	10-K	2023-02-15
Annual	2021-12-31	246800000.0	-2.9%	shares	10-K	2024-02-21
Annual	2022-12-31	242800000.0	-1.6%	shares	10-K	2025-02-20
Annual	2023-12-31	237400000.0	-2.2%	shares	10-K	2026-02-06
Annual	2024-12-31	232900000.0	-1.9%	shares	10-K	2026-02-06
Annual	2025-12-31	224600000.0	-3.6%	shares	10-K	2026-02-06

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

31,896,000,000

Total Liabilities (latest annual)

77,468,000,000

Current Liabilities (latest annual)

41,035,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.0299	—	ratio	10-Q	2017-04-26
Quarterly	2016-06-30	0.0322	+7.9%	ratio	10-Q	2017-07-26
Quarterly	2016-09-30	0.0250	-22.5%	ratio	10-Q	2017-10-25
Quarterly	2017-03-31	0.0387	+55.0%	ratio	10-Q	2018-04-25
Quarterly	2017-06-30	0.0324	-16.4%	ratio	10-Q	2018-07-25
Quarterly	2017-09-30	0.0288	-11.0%	ratio	10-Q	2018-10-31
Quarterly	2018-03-31	0.0486	+68.7%	ratio	10-Q	2019-10-23
Quarterly	2018-06-30	0.0367	-24.5%	ratio	10-Q	2019-10-23
Quarterly	2018-09-30	0.0330	-10.0%	ratio	10-Q	2019-10-23
Quarterly	2019-03-31	0.0517	+56.7%	ratio	10-Q	2020-10-28
Quarterly	2019-06-30	0.0370	-28.5%	ratio	10-Q	2020-10-28
Quarterly	2019-09-30	0.0378	+2.1%	ratio	10-Q	2020-10-28
Quarterly	2020-03-31	0.0481	+27.3%	ratio	10-Q	2021-10-20
Quarterly	2020-06-30	0.0661	+37.5%	ratio	10-Q	2021-10-20
Quarterly	2020-09-30	0.0065	-90.1%	ratio	10-Q	2021-10-20
Quarterly	2020-12-31	0.1378	+2005.0%	ratio	10-Q	2023-10-18
Quarterly	2021-03-31	0.0491	-64.3%	ratio	10-Q	2022-10-19
Quarterly	2021-06-30	0.0514	+4.6%	ratio	10-Q	2022-10-19
Quarterly	2021-09-30	0.0419	-18.4%	ratio	10-Q	2022-10-19
Quarterly	2021-12-31	0.1700	+305.4%	ratio	10-Q	2023-10-18
Quarterly	2022-03-31	0.0493	-71.0%	ratio	10-Q	2023-10-18
Quarterly	2022-06-30	0.0455	-7.7%	ratio	10-Q	2023-10-18
Quarterly	2022-09-30	0.0443	-2.7%	ratio	10-Q	2023-10-18
Quarterly	2022-12-31	0.1621	+265.7%	ratio	10-Q	2023-10-18
Quarterly	2023-03-31	0.0535	-67.0%	ratio	10-Q	2024-10-17
Quarterly	2023-06-30	0.0484	-9.4%	ratio	10-Q	2024-10-17
Quarterly	2023-09-30	0.0337	-30.4%	ratio	10-Q	2024-10-17
Quarterly	2024-03-31	0.0552	+63.8%	ratio	10-Q	2025-10-21
Quarterly	2024-06-30	0.0544	-1.5%	ratio	10-Q	2025-10-21
Quarterly	2024-09-30	0.0230	-57.8%	ratio	10-Q	2025-10-21
Quarterly	2025-03-31	0.0512	+123.1%	ratio	10-Q	2025-10-21
Quarterly	2025-06-30	0.0398	-22.4%	ratio	10-Q	2025-10-21
Quarterly	2025-09-30	0.0269	-32.3%	ratio	10-Q	2025-10-21
Annual	2016-12-31	0.0984	—	ratio	10-K	2019-02-20
Annual	2017-12-31	0.1450	+47.4%	ratio	10-K	2020-02-19
Annual	2018-12-31	0.1313	-9.5%	ratio	10-K	2021-02-18
Annual	2019-12-31	0.1517	+15.5%	ratio	10-K	2022-02-16
Annual	2020-12-31	0.1378	-9.2%	ratio	10-K	2023-02-15
Annual	2021-12-31	0.1701	+23.5%	ratio	10-K	2024-02-21
Annual	2022-12-31	0.1621	-4.7%	ratio	10-K	2025-02-20
Annual	2023-12-31	0.1520	-6.2%	ratio	10-K	2026-02-06
Annual	2024-12-31	0.1441	-5.2%	ratio	10-K	2026-02-06
Annual	2025-12-31	0.1286	-10.8%	ratio	10-K	2026-02-06

8-K Material Event Details

62 filings · 99 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

491 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-12	SCHULMAN AMY W	Dir	Open-market sell S	Common Stock	26	$287.50	$7,475	218
2026-03-06	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	3,196	$284.92	$910,604	11,791
2026-03-05	COLLIS STEVEN H	Dir	Open-market buy P	Common Stock	3,000	$289.84	$869,520	3,639
2026-03-03	Penczek Ronald W	CAO & Controller	Other disposed transaction F	Common Stock	37	$284.03	$10,509	4,099
2026-03-02	Penczek Ronald W	CAO & Controller	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	1,677	$0.00	$0	1,677
2026-03-02	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	266	$0.00	$0	4,136
2026-03-02	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	1,701	$0.00	$0	3,870
2026-03-02	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	426	$0.00	$0	2,169
2026-03-02	Penczek Ronald W	CAO & Controller	Other disposed transaction F	Common Stock	131	$294.07	$38,523	1,743
2026-02-02	SCHULMAN AMY W	Dir	Equity grant / award A	Common Stock	218	$0.00	$0	218
2025-10-02	Kaye Mark	EVP & CFO	Other disposed transaction F	Common Stock	2,895	$340.24	$984,995	16,082
2025-09-03	Wessling Erin M	EVP & Chief Legal Officer	Other disposed transaction F	Common Stock	152	$321.59	$48,882	5,020
2025-09-02	Wessling Erin M	EVP & Chief Legal Officer	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	3,541	$0.00	$0	3,541
2025-09-02	Wessling Erin M	EVP & Chief Legal Officer	Equity grant / award A	Common Stock	931	$0.00	$0	5,172
2025-08-19	DeVore Susan D.	Dir	Open-market buy P	Common Stock	1,200	$312.15	$374,580	3,502
2025-08-01	COLLIS STEVEN H	Dir	Equity grant / award A	Common Stock	639	$0.00	$0	639
2025-07-18	BOUDREAUX GAIL	President and CEO	Open-market buy P	Common Stock	1,050	$287.96	$302,358	151,020
2025-07-18	BOUDREAUX GAIL	President and CEO	Open-market buy P	Common Stock	5,116	$287.12	$1,468,906	149,970
2025-07-18	BOUDREAUX GAIL	President and CEO	Open-market buy P	Common Stock	2,334	$286.07	$667,687	144,854
2025-05-14	STRABLE-SOETHOUT DEANNA D	Dir	Equity grant / award A	Common Stock	601	$0.00	$0	1,646
2025-04-24	Kaye Mark	EVP & CFO	Open-market sell S	Common Stock	4,588	$424.82	$1,949,074	18,977
2025-03-10	Penczek Ronald W	CAO & Controller	Open-market sell S	Common Stock	443	$415.13	$183,903	1,847
2025-03-05	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	3,504	$396.30	$1,388,635	10,116
2025-03-03	Kendrick Charles Morgan JR	EVP & President, Commercial	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	10,828	$0.00	$0	10,828
2025-03-03	Kendrick Charles Morgan JR	EVP & President, Commercial	Equity grant / award A	Common Stock	3,686	$0.00	$0	13,620
2025-03-03	Kendrick Charles Morgan JR	EVP & President, Commercial	Equity grant / award A	Common Stock	2,845	$0.00	$0	9,934
2025-03-03	Kendrick Charles Morgan JR	EVP & President, Commercial	Other disposed transaction F	Common Stock	2,221	$395.50	$878,406	7,089
2025-01-03	Todt Blair Williams	EVP, CLO & CAO	Other disposed transaction F	Common Stock	398	$371.56	$147,881	15,631
2024-11-01	Kendrick Charles Morgan JR	EVP & President, Commercial	Equity grant / award A	Common Stock	1,710	$0.00	$0	9,287
2024-11-01	Kendrick Charles Morgan JR	EVP & President, Commercial	Other disposed transaction F	Common Stock	846	$414.01	$350,252	7,577
2024-10-18	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	7,417	$432.14	$3,205,182	8,423
2024-10-02	Kaye Mark	EVP & CFO	Other disposed transaction F	Common Stock	2,818	$505.16	$1,423,541	20,213
2024-08-05	PERU RAMIRO G	Dir	Open-market sell S	Common Stock	753	$531.52	$400,235	8,744
2024-07-22	BOUDREAUX GAIL	President and CEO	Open-market sell S	Common Stock	1,000	$503.67	$503,670	128,959
2024-07-22	BOUDREAUX GAIL	President and CEO	Open-market sell S	Common Stock	2,250	$504.27	$1,134,608	126,709
2024-07-22	BOUDREAUX GAIL	President and CEO	Open-market sell S	Common Stock	6,621	$501.40	$3,319,769	132,209
2024-07-22	BOUDREAUX GAIL	President and CEO	Open-market sell S	Common Stock	20,779	$500.36	$10,396,980	138,830
2024-07-22	BOUDREAUX GAIL	President and CEO	Open-market sell S	Common Stock	1,100	$498.50	$548,350	159,609
2024-07-19	Dixon Robert L JR	Dir	Open-market sell S	Common Stock	305	$506.76	$154,562	9,721
2024-05-15	Tallett Elizabeth E	Dir	Equity grant / award A	Common Stock	388	$0.00	$0	10,291
2024-04-24	Norwood Felicia F	EVP & President,Gov Health Ben	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	2,043	$0.00	$0	0
2024-04-24	Norwood Felicia F	EVP & President,Gov Health Ben	Open-market sell S	Common Stock	3,434	$532.68	$1,829,223	27,304
2024-04-24	Norwood Felicia F	EVP & President,Gov Health Ben	Open-market sell S	Common Stock	2,765	$532.14	$1,471,367	30,738
2024-04-24	Norwood Felicia F	EVP & President,Gov Health Ben	Exercise / conversion M	Common Stock	2,043	$238.27	$486,786	33,503
2024-04-23	Norwood Felicia F	EVP & President,Gov Health Ben	Exercise / conversion M · derivative	Employee Stock Option (right to buy)	5,473	$0.00	$0	2,043
2024-04-23	Norwood Felicia F	EVP & President,Gov Health Ben	Open-market sell S	Common Stock	100	$534.74	$53,474	31,460
2024-04-23	Norwood Felicia F	EVP & President,Gov Health Ben	Open-market sell S	Common Stock	14,011	$533.73	$7,478,091	31,560
2024-04-23	Norwood Felicia F	EVP & President,Gov Health Ben	Exercise / conversion M	Common Stock	5,473	$238.27	$1,304,052	45,571
2024-03-08	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	2,432	$500.46	$1,217,119	15,840
2024-03-06	Penczek Ronald W	CAO & Controller	Open-market sell S	Common Stock	916	$504.58	$462,195	1,764
2024-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	867	$0.00	$0	867
2024-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	1,046	$0.00	$0	2,680
2024-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	226	$0.00	$0	1,634
2024-03-01	Penczek Ronald W	CAO & Controller	Other disposed transaction F	Common Stock	383	$499.11	$191,159	1,408
2024-02-07	PERU RAMIRO G	Dir	Open-market sell S	Common Stock	753	$500.00	$376,500	9,109
2024-01-03	Todt Blair Williams	EVP, CLO & CAO	Other disposed transaction F	Common Stock	397	$480.49	$190,755	12,115
2023-12-14	Todt Blair Williams	EVP, CLO & CAO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	5,492	$0.00	$0	2,746
2023-12-14	Todt Blair Williams	EVP, CLO & CAO	Open-market sell S	Common Stock	5,492	$484.02	$2,658,238	12,512
2023-12-14	Todt Blair Williams	EVP, CLO & CAO	Exercise / conversion M	Common Stock	5,492	$311.48	$1,710,648	18,004
2023-12-01	Todt Blair Williams	EVP, CLO & CAO	Other disposed transaction F	Common Stock	1,127	$483.12	$544,476	16,029
2023-11-30	Penczek Ronald W	CAO & Controller	Open-market sell S	Common Stock	1,055	$475.17	$501,304	1,787
2023-11-01	Haytaian Peter D	EVP & Pres Carelon & CarelonRx	Other disposed transaction F	Common Stock	154	$446.66	$68,786	17,739
2023-10-24	Penczek Ronald W	CAO & Controller	Open-market sell S	Common Stock	64	$454.35	$29,078	2,842
2023-10-02	Kaye Mark	EVP & CFO Designate	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	8,076	$0.00	$0	8,076
2023-10-02	Kaye Mark	EVP & CFO Designate	Equity grant / award A	Common Stock	2,102	$0.00	$0	20,276
2023-10-02	Kaye Mark	EVP & CFO Designate	Equity grant / award A	Common Stock	18,174	$0.00	$0	18,174
2023-07-21	Dixon Robert L JR	Dir	Open-market sell S	Common Stock	310	$476.71	$147,780	9,638
2023-05-10	PERU RAMIRO G	Dir	Equity grant / award A	Common Stock	457	$0.00	$0	9,862
2023-03-24	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	3,625	$446.06	$1,616,968	51,435
2023-03-24	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	5,573	$445.30	$2,481,657	55,060
2023-03-24	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	3,000	$444.33	$1,332,990	60,633
2023-03-24	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	1,800	$443.27	$797,886	63,633
2023-03-24	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	500	$442.02	$221,010	65,433
2023-03-24	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	600	$440.78	$264,468	65,933
2023-03-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	2,314	$462.22	$1,069,577	15,327
2023-03-02	Penczek Ronald W	CAO & Controller	Other disposed transaction F	Common Stock	380	$468.78	$178,136	2,882
2023-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	819	$0.00	$0	819
2023-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	1,195	$0.00	$0	3,262
2023-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	214	$0.00	$0	2,067
2023-03-01	Penczek Ronald W	CAO & Controller	Other disposed transaction F	Common Stock	64	$469.03	$30,018	1,853
2023-01-03	Todt Blair Williams	EVP and Chief Legal Officer	Equity grant / award A	Common Stock	3,983	$0.00	$0	8,283
2022-12-30	Norwood Felicia F	EVP & President, GBD	Other disposed transaction F	Common Stock	1,754	$512.97	$899,749	26,684
2022-12-01	Todt Blair Williams	EVP and Chief Legal Officer	Other disposed transaction F	Common Stock	117	$525.25	$61,454	4,300
2022-11-04	BOUDREAUX GAIL	President and CEO	Equity grant / award G	Common Stock	10,000	$0.00	$0	111,415
2022-11-01	Kendrick Charles Morgan JR	EVP & President, Commercial	Other disposed transaction F	Common Stock	79	$544.53	$43,018	14,450
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	987	$0.00	$0	1,976
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	568	$0.00	$0	0
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,774	$0.00	$0	1,387
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,999	$0.00	$0	0
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	206	$491.39	$101,226	14,529
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	522	$490.83	$256,213	14,735
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	784	$489.49	$383,760	15,257
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	2,616	$488.64	$1,278,282	16,041
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Open-market sell S	Common Stock	2,200	$487.45	$1,072,390	18,657
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M	Common Stock	987	$311.48	$307,431	20,857
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M	Common Stock	568	$232.04	$131,799	19,870
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M	Common Stock	2,774	$271.27	$752,503	19,302
2022-06-09	Kendrick Charles Morgan JR	EVP & President, Commercial	Exercise / conversion M	Common Stock	1,999	$307.68	$615,052	16,528
2022-06-06	Dixon Robert L JR	Dir	Open-market sell S	Common Stock	420	$497.14	$208,799	9,491
2022-05-18	Neri Antonio F	Dir	Equity grant / award A	Common Stock	440	$0.00	$0	3,479
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,848	$0.00	$0	0
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Open-market sell S	Common Stock	40	$463.40	$18,536	12,161
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Open-market sell S	Common Stock	1,240	$462.73	$573,785	12,201
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Open-market sell S	Common Stock	5,874	$461.72	$2,712,143	13,441
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Open-market sell S	Common Stock	4,105	$460.68	$1,891,091	19,315
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Open-market sell S	Common Stock	4,274	$459.75	$1,964,972	23,420
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Open-market sell S	Common Stock	2,170	$458.68	$995,336	27,694
2022-03-10	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Exercise / conversion M	Common Stock	1,848	$131.80	$243,566	29,864
2022-03-03	Penczek Ronald W	CAO & Controller	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	468	$0.00	$0	0
2022-03-03	Penczek Ronald W	CAO & Controller	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	653	$0.00	$0	654
2022-03-03	Penczek Ronald W	CAO & Controller	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	438	$0.00	$0	877
2022-03-03	Penczek Ronald W	CAO & Controller	Open-market sell S	Common Stock	2,423	$463.68	$1,123,497	1,902
2022-03-03	Penczek Ronald W	CAO & Controller	Exercise / conversion M	Common Stock	468	$307.68	$143,994	4,325
2022-03-03	Penczek Ronald W	CAO & Controller	Exercise / conversion M	Common Stock	653	$271.27	$177,139	3,857
2022-03-03	Penczek Ronald W	CAO & Controller	Exercise / conversion M	Common Stock	438	$311.48	$136,428	3,204
2022-03-02	Penczek Ronald W	CAO & Controller	Other disposed transaction F	Common Stock	52	$463.49	$24,101	2,766
2022-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	882	$0.00	$0	882
2022-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	953	$0.00	$0	2,818
2022-03-01	Penczek Ronald W	CAO & Controller	Equity grant / award A	Common Stock	222	$0.00	$0	1,865
2022-03-01	Penczek Ronald W	CAO & Controller	Other disposed transaction F	Common Stock	369	$451.50	$166,604	1,643
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	653	$0.00	$0	1,307
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	357	$0.00	$0	0
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	935	$0.00	$0	468
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	818	$0.00	$0	0
2022-02-07	Penczek Ronald W	CAO & Controller	Open-market sell S	Common Stock	2,763	$453.48	$1,252,965	2,012
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M	Common Stock	653	$271.27	$177,139	4,775
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M	Common Stock	357	$166.97	$59,608	4,122
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M	Common Stock	935	$307.68	$287,681	3,765
2022-02-07	Penczek Ronald W	CAO & Controller	Exercise / conversion M	Common Stock	818	$232.04	$189,809	2,830
2021-12-30	Norwood Felicia F	EVP & President, GBD	Other disposed transaction F	Common Stock	1,754	$467.15	$819,381	23,256
2021-12-01	Todt Blair Williams	EVP and Chief Legal Officer	Other disposed transaction F	Common Stock	79	$404.65	$31,967	2,725
2021-11-01	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	4,786	$0.00	$0	4,786
2021-11-01	Haytaian Peter D	EVP & Pres., DBG & IngenioRx	Equity grant / award A	Common Stock	1,167	$0.00	$0	22,711
2021-10-28	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	1,150	$436.00	$501,400	2,009
2021-10-01	Alter Jeffrey D.	EVP, IngenioRx & Anthem Health	Other disposed transaction F	Common Stock	311	$375.93	$116,914	5,107
2021-09-04	Patel Prakash R	EVP & President, DBG	Other disposed transaction F	Common Stock	3,507	$377.71	$1,324,629	17,230
2021-09-01	DeVore Susan D.	Dir	Equity grant / award A	Common Stock	416	$0.00	$0	416
2021-07-23	Schneider Ryan M.	Dir	Open-market buy P	Common Stock	1,300	$384.36	$499,668	4,714
2021-07-02	Norwood Felicia F	EVP & President, GBD	Other disposed transaction F	Common Stock	5,543	$387.20	$2,146,250	25,010
2021-05-26	Neri Antonio F	Dir	Equity grant / award A	Common Stock	493	$0.00	$0	3,039
2021-05-24	PERU RAMIRO G	Dir	Open-market sell S	Common Stock	1,308	$398.02	$520,610	9,462
2021-05-21	Dixon Robert L JR	Dir	Open-market sell S	Common Stock	590	$392.87	$231,793	8,978
2021-05-20	HILL JULIE A	Dir	Open-market sell S	Common Stock	1,308	$394.00	$515,352	31,213
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	22,500	$0.00	$0	1,848
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	15,593	$0.00	$0	0
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	2,329	$352.84	$821,764	22,544
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	400	$351.32	$140,528	24,873
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	7,891	$350.21	$2,763,507	25,273
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	26,777	$349.53	$9,359,365	33,164
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	12,416	$348.52	$4,327,224	59,941
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	9,387	$347.44	$3,261,419	72,357
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	300	$345.59	$103,677	81,744
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	22,500	$131.80	$2,965,500	82,044
2021-03-22	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	15,593	$146.93	$2,291,079	59,544
2021-03-05	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	2,068	$333.94	$690,588	3,137
2021-03-04	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	67	$323.56	$21,679	5,205
2021-03-02	BOUDREAUX GAIL	President and CEO	Other disposed transaction F	Common Stock	1,644	$311.66	$512,369	100,300
2021-03-01	BOUDREAUX GAIL	President and CEO	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	43,501	$0.00	$0	43,501
2021-03-01	BOUDREAUX GAIL	President and CEO	Equity grant / award A	Common Stock	73,240	$0.00	$0	101,944
2021-03-01	BOUDREAUX GAIL	President and CEO	Equity grant / award A	Common Stock	10,595	$0.00	$0	28,704
2021-03-01	BOUDREAUX GAIL	President and CEO	Other disposed transaction F	Common Stock	35,564	$311.48	$11,077,475	18,109
2021-02-04	Schneider Ryan M.	Dir	Open-market buy P	Common Stock	1,700	$296.03	$503,251	2,921
2020-12-30	STARK LEAH	EVP & CHRO	Other disposed transaction F	Common Stock	328	$314.05	$103,008	11,952
2020-12-15	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	5,833	$0.00	$0	15,593
2020-12-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	100	$313.42	$31,342	32,642
2020-12-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	3,836	$312.76	$1,199,747	32,742
2020-12-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,897	$312.01	$591,883	36,578
2020-12-15	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	5,833	$146.93	$857,043	38,475
2020-12-08	Gallina John E	EVP & Chief Financial Officer	Equity grant / award G	Common Stock	2,589	$0.00	$0	39,204
2020-12-01	Todt Blair Williams	EVP and Chief Legal Officer	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	4,232	$0.00	$0	4,232
2020-12-01	Todt Blair Williams	EVP and Chief Legal Officer	Equity grant / award A	Common Stock	797	$0.00	$0	797
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	927	$0.00	$0	21,426
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	781	$0.00	$0	0
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	300	$337.00	$101,100	32,642
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	675	$335.92	$226,746	32,942
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,193	$334.87	$399,500	33,617
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,200	$333.97	$400,764	34,810
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,056	$332.86	$351,500	36,010
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	400	$331.92	$132,768	37,066
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,010	$330.77	$334,078	37,466
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	927	$146.93	$136,204	38,476
2020-11-16	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	781	$100.77	$78,701	37,549
2020-11-09	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	1,199	$330.75	$396,569	3,229
2020-11-03	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,893	$0.00	$0	1,893
2020-11-03	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	1,893	$292.32	$553,362	17,910
2020-11-03	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	1,893	$232.04	$439,252	19,803
2020-11-03	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	2,500	$292.35	$730,875	17,910
2020-11-03	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	2	$292.64	$585	20,410
2020-11-03	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	4,780	$292.07	$1,396,095	20,412
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,667	$0.00	$0	781
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,167	$295.00	$344,265	36,768
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	147	$293.98	$43,215	37,935
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,120	$293.33	$328,530	38,082
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,600	$292.13	$467,408	39,202
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	800	$290.30	$232,240	40,802
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,000	$287.58	$287,580	41,602
2020-10-15	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	4,667	$100.77	$470,294	42,602
2020-10-09	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,167	$295.00	$344,265	37,935
2020-10-02	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,592	$0.00	$0	5,448
2020-10-02	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,075	$0.00	$0	0
2020-10-02	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	4,667	$280.00	$1,306,760	39,102
2020-10-02	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	2,592	$100.77	$261,196	43,769
2020-10-02	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	2,075	$89.44	$185,588	41,177
2020-10-01	Alter Jeffrey D.	EVP, IngenioRx & Anthem Health	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	10,659	$0.00	$0	10,659
2020-10-01	Alter Jeffrey D.	EVP, IngenioRx & Anthem Health	Equity grant / award A	Common Stock	2,746	$0.00	$0	2,746
2020-09-04	Patel Prakash R	EVP & President, DBG	Other disposed transaction F	Common Stock	118	$276.22	$32,594	12,073
2020-07-02	Norwood Felicia F	EVP & President, GBD	Other disposed transaction F	Common Stock	231	$267.00	$61,677	18,181
2020-06-08	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	545	$297.74	$162,268	4,400
2020-05-27	Dixon Robert L JR	Dir	Open-market sell S	Common Stock	1,102	$284.59	$313,618	9,568
2020-05-21	Neri Antonio F	Dir	Equity grant / award A	Common Stock	699	$0.00	$0	2,546
2020-05-19	HILL JULIE A	Dir	Open-market sell S	Common Stock	1,102	$283.26	$312,153	31,822
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	18,261	$0.00	$0	0
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	763	$279.18	$213,014	42,099
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	2,356	$278.22	$655,486	42,862
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	5,983	$277.02	$1,657,411	45,218
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	5,013	$276.11	$1,384,139	51,201
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	1,600	$275.00	$440,000	56,214
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	100	$273.31	$27,331	57,814
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	845	$272.91	$230,609	57,914
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	1,601	$271.09	$434,015	58,759
2020-05-15	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	18,261	$131.80	$2,406,800	60,360
2020-04-30	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,553	$0.00	$0	0
2020-04-30	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,892	$0.00	$0	3,786
2020-04-30	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	14,861	$278.17	$4,133,884	31,550
2020-04-30	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	4,445	$278.90	$1,239,710	46,411
2020-04-30	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	2,553	$166.97	$426,274	50,856
2020-04-30	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	1,892	$232.04	$439,020	48,303
2020-04-16	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	16,884	$270.00	$4,558,680	42,099
2020-04-03	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Other disposed transaction F	Common Stock	4,415	$203.30	$897,570	58,983
2020-03-02	Patel Prakash R	EVP & President, DBG	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	12,253	$0.00	$0	12,253
2020-03-02	Patel Prakash R	EVP & President, DBG	Equity grant / award A	Common Stock	5,991	$0.00	$0	12,191
2020-03-02	Patel Prakash R	EVP & President, DBG	Other disposed transaction F	Common Stock	185	$271.27	$50,185	6,200
2020-01-30	BOUDREAUX GAIL	President and CEO	Open-market buy P	Common Stock	2,000	$264.22	$528,440	26,556
2020-01-30	BOUDREAUX GAIL	President and CEO	Open-market buy P	Common Stock	5,600	$263.52	$1,475,712	24,556
2019-12-30	STARK LEAH	EVP & CHRO	Equity grant / award A	Common Stock	3,276	$0.00	$0	4,983
2019-12-24	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	4,166	$303.82	$1,265,714	20,949
2019-12-20	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	4,167	$303.32	$1,263,934	25,115
2019-12-04	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,553	$0.00	$0	2,553
2019-12-04	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,892	$0.00	$0	5,678
2019-12-04	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,064	$0.00	$0	0
2019-12-04	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	10,600	$288.33	$3,056,298	29,092
2019-12-04	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	2,553	$166.97	$426,274	39,692
2019-12-04	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	1,892	$232.04	$439,020	37,139
2019-12-04	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	3,064	$108.35	$331,984	35,247
2019-11-18	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,762	$0.00	$0	0
2019-11-18	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	12,095	$300.00	$3,628,500	29,282
2019-11-18	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	3,762	$61.88	$232,793	41,377
2019-11-13	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	816	$0.00	$0	818
2019-11-13	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	816	$287.00	$234,192	1,938
2019-11-13	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	816	$232.04	$189,345	2,754
2019-11-12	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	357	$0.00	$0	357
2019-11-12	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	357	$282.00	$100,674	1,938
2019-11-12	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	357	$166.97	$59,608	2,295
2019-10-28	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	4,873	$270.05	$1,315,954	37,615
2019-10-28	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	4,713	$269.08	$1,268,174	42,488
2019-10-03	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Other disposed transaction F	Common Stock	617	$238.23	$146,988	38,126
2019-10-01	Schneider Ryan M.	Dir	Equity grant / award A	Common Stock	522	$0.00	$0	522
2019-09-04	Patel Prakash R	EVP & President, DBG	Other disposed transaction F	Common Stock	109	$254.23	$27,711	3,109
2019-07-26	HILL JULIE A	Dir	Open-market sell S	Common Stock	1,656	$295.00	$488,520	32,924
2019-07-02	Norwood Felicia F	Exec VP & President, GBD	Other disposed transaction F	Common Stock	176	$280.66	$49,396	3,843
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,382	$0.00	$0	0
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,552	$0.00	$0	5,106
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,892	$0.00	$0	7,570
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,000	$0.00	$0	3,064
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	8,826	$283.92	$2,505,878	32,183
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	3,382	$131.80	$445,748	41,009
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	2,552	$166.97	$426,107	37,627
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	1,892	$232.04	$439,020	35,075
2019-06-11	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	1,000	$108.35	$108,350	33,183
2019-06-03	Gallina John E	EVP & Chief Financial Officer	Other disposed transaction F	Common Stock	2,033	$276.44	$562,003	18,751
2019-05-30	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	406	$0.00	$0	0
2019-05-30	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	357	$0.00	$0	714
2019-05-30	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	763	$279.00	$212,877	1,938
2019-05-30	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	406	$131.80	$53,511	2,701
2019-05-30	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	357	$166.97	$59,608	2,295
2019-05-21	PERU RAMIRO G	Dir	Open-market sell S	Common Stock	1,656	$275.00	$455,400	11,173
2019-05-15	Tallett Elizabeth E	Dir	Equity grant / award A	Common Stock	753	$0.00	$0	7,814
2019-04-03	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Other disposed transaction F	Common Stock	185	$287.66	$53,217	38,743
2019-03-20	Gallina John E	EVP & Chief Financial Officer	Equity grant / award G	Common Stock	2,272	$0.00	$0	20,784
2019-03-01	ZIELINSKI THOMAS C	EVP & General Counsel	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	9,378	$0.00	$0	9,378
2019-03-01	ZIELINSKI THOMAS C	EVP & General Counsel	Equity grant / award A	Common Stock	2,032	$0.00	$0	32,183
2019-03-01	ZIELINSKI THOMAS C	EVP & General Counsel	Equity grant / award A	Common Stock	10,138	$0.00	$0	30,151
2019-03-01	ZIELINSKI THOMAS C	EVP & General Counsel	Other disposed transaction F	Common Stock	6,071	$307.68	$1,867,925	20,013
2019-02-04	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	7,700	$0.00	$0	1,362
2019-02-04	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	2,992	$303.82	$909,029	38,756
2019-02-04	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	2,808	$302.84	$850,375	41,748
2019-02-04	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	1,900	$301.85	$573,515	44,556
2019-02-04	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	7,700	$146.93	$1,131,361	46,456
2019-01-31	HILL JULIE A	Dir	Open-market sell S	Common Stock	500	$299.75	$149,875	33,827
2019-01-18	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	7,700	$0.00	$0	9,062
2019-01-18	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	7,700	$265.00	$2,040,500	38,756
2019-01-18	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	7,700	$265.00	$2,040,500	46,456
2018-12-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	2,000	$256.95	$513,900	40,206
2018-12-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,000	$255.03	$255,030	42,206
2018-11-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	400	$280.35	$112,140	43,206
2018-11-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	900	$279.30	$251,370	43,606
2018-11-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	2,500	$278.22	$695,550	44,506
2018-11-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	700	$277.29	$194,103	47,006
2018-11-08	HILL JULIE A	Dir	Open-market sell S	Common Stock	500	$287.25	$143,625	34,327
2018-11-07	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,892	$0.00	$0	9,462
2018-11-07	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,552	$0.00	$0	7,658
2018-11-07	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,382	$0.00	$0	3,382
2018-11-07	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	7,826	$289.71	$2,267,270	26,084
2018-11-07	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	1,892	$232.04	$439,020	33,910
2018-11-07	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	2,552	$166.97	$426,107	32,018
2018-11-07	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	3,382	$131.80	$445,748	29,466
2018-10-31	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,000	$270.00	$270,000	21,544
2018-10-26	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	500	$269.10	$134,550	47,706
2018-10-26	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	3,000	$267.34	$802,020	48,206
2018-10-03	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Other disposed transaction F	Common Stock	84	$276.24	$23,204	38,756
2018-09-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	4,500	$270.00	$1,215,000	51,206
2018-09-06	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	1,936	$0.00	$0	0
2018-09-06	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,000	$270.00	$270,000	55,706
2018-09-06	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	1,936	$270.00	$522,720	56,706
2018-09-06	Haytaian Peter D	EVP & President, Commercial	Exercise / conversion M	Common Stock	1,936	$60.15	$116,450	58,642
2018-09-04	Patel Prakash R	EVP & President, DBG	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	4,993	$0.00	$0	4,993
2018-09-04	Patel Prakash R	EVP & President, DBG	Equity grant / award A	Common Stock	1,186	$0.00	$0	1,186
2018-08-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	968	$266.50	$257,972	56,706
2018-08-27	Haytaian Peter D	EVP & President, Commercial	Open-market sell S	Common Stock	2,532	$265.70	$672,752	57,674
2018-08-16	HILL JULIE A	Dir	Open-market sell S	Common Stock	248	$267.01	$66,218	34,827
2018-07-26	Samitt Craig E	EVP & President, DBG	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,594	$0.00	$0	9,188
2018-07-26	Samitt Craig E	EVP & President, DBG	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	11,364	$0.00	$0	5,682
2018-07-26	Samitt Craig E	EVP & President, DBG	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	9,846	$0.00	$0	1,970
2018-07-26	Samitt Craig E	EVP & President, DBG	Open-market sell S	Common Stock	19,541	$246.68	$4,820,374	17,274
2018-07-26	Samitt Craig E	EVP & President, DBG	Exercise / conversion M	Common Stock	4,594	$166.97	$767,060	36,815
2018-07-26	Samitt Craig E	EVP & President, DBG	Exercise / conversion M	Common Stock	11,364	$131.80	$1,497,775	32,221
2018-07-26	Samitt Craig E	EVP & President, DBG	Exercise / conversion M	Common Stock	9,846	$138.94	$1,368,003	20,857
2018-07-02	Norwood Felicia F	Exec VP & President, GBD	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	7,516	$0.00	$0	7,516
2018-07-02	Norwood Felicia F	Exec VP & President, GBD	Equity grant / award A	Common Stock	1,784	$0.00	$0	1,784
2018-06-01	Gallina John E	EVP & Chief Financial Officer	Other disposed transaction F	Common Stock	275	$221.50	$60,912	15,659
2018-05-25	HILL JULIE A	Dir	Open-market sell S	Common Stock	1,000	$233.00	$233,000	35,075
2018-05-18	PERU RAMIRO G	Dir	Open-market sell S	Common Stock	2,248	$231.57	$520,569	12,076
2018-05-16	Jallal Bahija	Dir	Equity grant / award A	Common Stock	753	$0.00	$0	957
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	6,636	$0.00	$0	13,272
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	16,232	$0.00	$0	8,116
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,478	$0.00	$0	896
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	14,830	$0.00	$0	0
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	7,489	$0.00	$0	0
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	9,756	$0.00	$0	0
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Open-market sell S	Common Stock	4,924	$225.35	$1,109,623	15,863
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Open-market sell S	Common Stock	54,497	$224.32	$12,224,767	20,787
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M	Common Stock	6,636	$166.97	$1,108,013	75,284
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M	Common Stock	16,232	$131.80	$2,139,378	68,648
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M	Common Stock	4,478	$152.78	$684,149	52,416
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M	Common Stock	14,830	$89.44	$1,326,395	47,938
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M	Common Stock	7,489	$146.93	$1,100,359	33,108
2018-05-03	GRIFFIN BRIAN T	EVP & CEO, IngenioRx	Exercise / conversion M	Common Stock	9,756	$61.88	$603,701	25,619
2018-04-03	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Other disposed transaction F	Common Stock	184	$227.51	$41,862	38,840
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	5,104	$0.00	$0	10,210
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	6,763	$0.00	$0	6,764
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	5,588	$0.00	$0	0
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,000	$0.00	$0	4,064
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	6,200	$229.80	$1,424,760	26,084
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	14,255	$228.98	$3,264,110	32,284
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	5,104	$166.97	$852,215	46,539
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	6,763	$131.80	$891,363	41,435
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	5,588	$146.93	$821,045	34,672
2018-03-13	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	3,000	$108.35	$325,050	29,084
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	357	$0.00	$0	1,428
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	405	$0.00	$0	812
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	217	$0.00	$0	0
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	987	$231.82	$228,806	928
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	979	$231.99	$227,118	1,915
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	357	$166.97	$59,608	2,894
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	405	$131.80	$53,379	2,537
2018-03-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	217	$146.93	$31,884	2,132
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,036	$0.00	$0	4,038
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	6,466	$0.00	$0	0
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,921	$0.00	$0	1,962
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,948	$0.00	$0	0
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Open-market sell S	Common Stock	4,100	$231.29	$948,289	15,934
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Open-market sell S	Common Stock	5,372	$230.44	$1,237,924	20,034
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Open-market sell S	Common Stock	15,104	$229.19	$3,461,686	25,406
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M	Common Stock	4,036	$132.51	$534,810	40,510
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M	Common Stock	6,466	$89.44	$578,319	36,474
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M	Common Stock	3,921	$131.80	$516,788	30,008
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Exercise / conversion M	Common Stock	3,948	$61.88	$244,302	26,087
2018-03-05	Gallina John E	EVP & Chief Financial Officer	Equity grant / award G	Common Stock	2,448	$0.00	$0	22,139
2018-03-02	ZIELINSKI THOMAS C	EVP & General Counsel	Equity grant / award A	Common Stock	12,228	$0.00	$0	26,084
2018-03-02	ZIELINSKI THOMAS C	EVP & General Counsel	Other disposed transaction F	Common Stock	5,482	$233.08	$1,277,745	13,856
2018-03-01	ZIELINSKI THOMAS C	EVP & General Counsel	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	11,354	$0.00	$0	11,354
2018-03-01	ZIELINSKI THOMAS C	EVP & General Counsel	Equity grant / award A	Common Stock	2,694	$0.00	$0	19,338
2018-03-01	ZIELINSKI THOMAS C	EVP & General Counsel	Other disposed transaction F	Common Stock	800	$232.04	$185,632	16,644
2018-02-01	Jallal Bahija	Dir	Equity grant / award A	Common Stock	204	$0.00	$0	204
2018-01-11	Swedish Joseph	Executive Chairman	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	67,500	$0.00	$0	46,600
2018-01-11	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	36,858	$236.28	$8,708,808	66,543
2018-01-11	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	23,364	$235.58	$5,504,091	103,401
2018-01-11	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	7,278	$234.73	$1,708,365	126,765
2018-01-11	Swedish Joseph	Executive Chairman	Exercise / conversion M	Common Stock	67,500	$89.44	$6,037,200	134,043
2018-01-04	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Open-market sell S	Common Stock	100	$230.08	$23,008	30,567
2018-01-04	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Open-market sell S	Common Stock	14,329	$229.68	$3,291,085	30,667
2018-01-02	Neri Antonio F	Dir	Equity grant / award A	Common Stock	341	$0.00	$0	341
2017-12-01	Swedish Joseph	Executive Chairman	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	21,125	$0.00	$0	17,803
2017-12-01	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	300	$235.67	$70,701	66,543
2017-12-01	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	800	$234.81	$187,848	66,843
2017-12-01	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	5,882	$232.08	$1,365,095	68,443
2017-12-01	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	7,722	$231.24	$1,785,635	74,325
2017-12-01	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	4,321	$230.43	$995,688	82,047
2017-12-01	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	1,100	$229.13	$252,043	86,368
2017-12-01	Swedish Joseph	Executive Chairman	Open-market sell S	Common Stock	200	$227.31	$45,462	87,468
2017-12-01	Swedish Joseph	Executive Chairman	Exercise / conversion M	Common Stock	21,125	$67.44	$1,424,670	87,668
2017-11-10	LOGEN ASSET MANAGEMENT LP	10%	Open-market sell S	Class A Common Stock	156,290	$0.02	$3,282	0
2017-11-10	LOGEN ASSET MANAGEMENT LP	10%	Open-market sell S	Class A Common Stock	1,890,923	$0.02	$39,709	0
2017-11-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	356	$0.00	$0	1,785
2017-11-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	405	$0.00	$0	1,217
2017-11-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	217	$0.00	$0	217
2017-11-07	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	978	$217.42	$212,637	1,005
2017-11-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	356	$166.97	$59,441	1,983
2017-11-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	405	$131.80	$53,379	1,627
2017-11-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	217	$146.93	$31,884	1,222
2017-11-01	Swedish Joseph	Chair, President & CEO	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	21,125	$0.00	$0	38,928
2017-11-01	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	300	$210.79	$63,237	66,543
2017-11-01	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	10,146	$210.22	$2,132,892	66,843
2017-11-01	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	10,679	$209.47	$2,236,930	76,989
2017-11-01	Swedish Joseph	Chair, President & CEO	Exercise / conversion M	Common Stock	21,125	$67.44	$1,424,670	87,668
2017-10-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Other disposed transaction F	Common Stock	88	$193.23	$17,004	44,996
2017-10-02	Samitt Craig E	EVP & Chief Clinical Officer	Other disposed transaction F	Common Stock	375	$191.11	$71,666	8,994
2017-09-01	Wolf Jacquelyn H	EVP & Chief HR Officer	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	3,882	$0.00	$0	3,882
2017-09-01	Wolf Jacquelyn H	EVP & Chief HR Officer	Equity grant / award A	Common Stock	950	$0.00	$0	950
2017-08-10	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	9,127	$0.00	$0	7,064
2017-08-10	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	1,000	$192.76	$192,760	17,444
2017-08-10	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	5,027	$191.82	$964,279	18,444
2017-08-10	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	3,100	$189.85	$588,535	23,471
2017-08-10	ZIELINSKI THOMAS C	EVP & General Counsel	Exercise / conversion M	Common Stock	9,127	$108.35	$988,910	26,571
2017-08-03	GRIFFIN BRIAN T	EVP & President, CSBD	Other disposed transaction F	Common Stock	213	$191.44	$40,777	20,078
2017-06-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	867	$0.00	$0	434
2017-06-07	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	867	$187.46	$162,528	1,005
2017-06-07	Penczek Ronald W	SVP, Chief Accounting Officer	Exercise / conversion M	Common Stock	867	$146.93	$127,388	1,872
2017-06-02	ZIELINSKI THOMAS C	EVP & General Counsel	Other disposed transaction F	Common Stock	3,071	$187.58	$576,058	17,444
2017-06-01	Gallina John E	EVP & Chief Financial Officer	Other disposed transaction F	Common Stock	291	$187.69	$54,618	19,222
2017-05-30	PERU RAMIRO G	Dir	Open-market sell S	Common Stock	2,681	$181.58	$486,816	13,571
2017-05-24	HILL JULIE A	Dir	Open-market sell S	Common Stock	555	$180.56	$100,211	37,448
2017-05-18	HAY LEWIS III	Dir	Equity grant / award A	Common Stock	990	$0.00	$0	6,923
2017-05-08	Gallina John E	EVP & Chief Financial Officer	Equity grant / award G	Common Stock	3,211	$0.00	$0	19,513
2017-05-01	Haytaian Peter D	EVP & President, GBD	Other disposed transaction F	Common Stock	1,690	$179.20	$302,848	46,046
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	4,606	$0.00	$0	4,606
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	4,606	$0.00	$0	4,606
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	14,271	$0.00	$0	0
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Equity grant / award A	Common Stock	1,127	$0.00	$0	45,084
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Open-market sell S	Common Stock	300	$167.45	$50,235	43,957
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Open-market sell S	Common Stock	7,416	$166.91	$1,237,805	44,257
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Open-market sell S	Common Stock	7,471	$165.81	$1,238,767	51,673
2017-04-03	MCCARTHY GLORIA M	EVP & Chief Transformation Off	Exercise / conversion M	Common Stock	14,271	$89.44	$1,276,398	59,144
2017-03-03	Tomas Jose D.	EVP & Chief HR Officer	Other disposed transaction F	Common Stock	2,615	$166.00	$434,090	23,927
2017-03-02	GRIFFIN BRIAN T	EVP & President, CSBD	Other disposed transaction F	Common Stock	213	$165.97	$35,352	24,610
2017-03-01	GRIFFIN BRIAN T	EVP & President, CSBD	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	19,908	$0.00	$0	19,908
2017-03-01	GRIFFIN BRIAN T	EVP & President, CSBD	Equity grant / award A	Common Stock	4,867	$0.00	$0	24,823
2017-03-01	GRIFFIN BRIAN T	EVP & President, CSBD	Other disposed transaction F	Common Stock	706	$166.97	$117,881	19,956
2017-01-09	Tomas Jose D.	EVP & Chief HR Officer	Open-market sell S	Common Stock	6,500	$142.92	$928,980	23,913
2016-12-14	Haytaian Peter D	EVP & President, GBD	Other disposed transaction F	Common Stock	654	$144.69	$94,627	45,765
2016-12-12	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	1,637	$145.19	$237,676	71,034
2016-12-12	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	2,930	$144.30	$422,799	72,671
2016-12-12	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	3,609	$143.44	$517,675	75,601
2016-12-02	Tomas Jose D.	EVP & Chief HR Officer	Other disposed transaction F	Common Stock	1,043	$145.10	$151,339	30,413
2016-11-22	Penczek Ronald W	SVP, Chief Accounting Officer	Open-market sell S	Common Stock	820	$138.29	$113,398	1,320
2016-11-11	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	8,171	$134.44	$1,098,509	79,210
2016-11-10	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	16,342	$130.00	$2,124,460	87,381
2016-10-03	Samitt Craig E	EVP & Chief Clinical Officer	Other disposed transaction F	Common Stock	276	$122.90	$33,920	6,408
2016-08-12	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	100	$131.05	$13,105	103,723
2016-08-12	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	8,071	$130.36	$1,052,136	103,823
2016-08-10	ZIELINSKI THOMAS C	EVP & General Counsel	Open-market sell S	Common Stock	5,254	$128.83	$676,873	17,935
2016-08-03	GRIFFIN BRIAN T	EVP & President, CSBD	Other disposed transaction F	Common Stock	213	$127.87	$27,236	28,452
2016-08-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,186	$0.00	$0	14,871
2016-08-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	586	$131.28	$76,930	45,240
2016-08-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	3,600	$130.25	$468,900	45,826
2016-08-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	4,186	$89.44	$374,396	49,426
2016-07-28	RYAN WILLIAM J	Dir	Open-market sell S	Common Stock	3,125	$133.15	$416,094	27,149
2016-07-11	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	700	$132.04	$92,428	111,894
2016-07-11	Swedish Joseph	Chair, President & CEO	Open-market sell S	Common Stock	7,471	$131.44	$981,988	112,594
2016-07-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	3,859	$0.00	$0	19,057
2016-07-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	927	$0.00	$0	0
2016-07-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	1,786	$131.69	$235,198	45,240
2016-07-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	3,000	$130.96	$392,880	47,026
2016-07-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	3,859	$89.44	$345,149	50,026
2016-07-01	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	927	$77.50	$71,842	46,167
2016-06-29	PERU RAMIRO G	Dir	Open-market sell S	Common Stock	3,125	$130.00	$406,250	15,262
2016-06-03	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Other disposed transaction F	Common Stock	1,055	$131.84	$139,091	45,240
2016-06-02	ZIELINSKI THOMAS C	EVP & General Counsel	Other disposed transaction F	Common Stock	2,768	$133.29	$368,947	23,189
2016-06-01	Gallina John E	EVP & Chief Financial Officer	Equity grant / award A · derivative	Employee Stock Option (Right to Buy)	8,074	$0.00	$0	8,074
2016-06-01	Gallina John E	EVP & Chief Financial Officer	Equity grant / award A	Common Stock	1,887	$0.00	$0	19,128
2016-05-19	HILL JULIE A	Dir	Equity grant / award A	Common Stock	1,308	$0.00	$0	37,013
2016-05-02	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,604	$0.00	$0	2,958
2016-05-02	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	2,182	$0.00	$0	0
2016-05-02	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	1,500	$141.58	$212,370	46,295
2016-05-02	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	3,286	$140.77	$462,570	47,795
2016-05-02	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	2,604	$77.50	$201,810	51,081
2016-05-02	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	2,182	$61.88	$135,022	48,477
2016-04-14	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M · derivative	Employee Stock Option (Right to Buy)	4,786	$0.00	$0	2,182
2016-04-14	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	1,200	$143.02	$171,624	46,295
2016-04-14	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Open-market sell S	Common Stock	3,586	$142.00	$509,212	47,495
2016-04-14	MCCARTHY GLORIA M	EVP & Chief Administrative Off	Exercise / conversion M	Common Stock	4,786	$61.88	$296,158	51,081

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count